BECTON, DICKINSON AND COMPANY Total Contract Liability
BECTON, DICKINSON AND COMPANY (BDX) had Total Contract Liability of $334.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-08-06
- 2026-06-30: Contract with Customer, Liability $334.00M.
- 2026-03-31: Contract with Customer, Liability $337.00M.
- 2025-12-31: Contract with Customer, Liability $457.00M.
- 2025-09-30: Contract with Customer, Liability $336.00M; Contract with Customer, Liability as first filed $481.00M.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2026-06-30 | $334.00M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $337.00M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $457.00M 10-Q · filed 2026-02-09 | |
| 2025-09-30 | $336.00M 10-Q · filed 2026-08-06 | $481.00M 10-K · filed 2025-11-25 |
| 2025-06-30 | $492.00M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $495.00M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $502.00M 10-Q · filed 2025-02-06 | |
| 2024-09-30 | $482.00M 10-K · filed 2025-11-25 | |
| 2024-06-30 | $449.00M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $440.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $419.00M 10-Q · filed 2024-02-01 | |
| 2023-09-30 | $412.00M 10-K · filed 2024-11-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |